» Articles » PMID: 35269675

The R369 Myosin Residue Within Loop 4 Is Critical for Actin Binding and Muscle Function in

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Mar 10
PMID 35269675
Authors
Affiliations
Soon will be listed here.
Abstract

The myosin molecular motor interacts with actin filaments in an ATP-dependent manner to yield muscle contraction. Myosin heavy chain residue R369 is located within loop 4 at the actin-tropomyosin interface of myosin's upper 50 kDa subdomain. To probe the importance of R369, we introduced a histidine mutation of that residue into myosin and implemented an integrative approach to determine effects at the biochemical, cellular, and whole organism levels. Substituting the similarly charged but bulkier histidine residue reduces maximal actin binding in vitro without affecting myosin ATPase activity. R369H mutants exhibit impaired flight ability that is dominant in heterozygotes and progressive with age in homozygotes. Indirect flight muscle ultrastructure is normal in mutant homozygotes, suggesting that assembly defects or structural deterioration of myofibrils are not causative of reduced flight. Jump ability is also reduced in homozygotes. In contrast to these skeletal muscle defects, R369H mutants show normal heart ultrastructure and function, suggesting that this residue is differentially sensitive to perturbation in different myosin isoforms or muscle types. Overall, our findings indicate that R369 is an actin binding residue that is critical for myosin function in skeletal muscles, and suggest that more severe perturbations at this residue may cause human myopathies through a similar mechanism.

Citing Articles

Exploring novel MYH7 gene variants using in silico analyses in Korean patients with cardiomyopathy.

Kim O, Kim J, Kim Y, Lee S, Lee B, Kim B BMC Med Genomics. 2024; 17(1):225.

PMID: 39237976 PMC: 11378590. DOI: 10.1186/s12920-024-02000-8.


Myosin loop-4 is critical for optimal tropomyosin repositioning on actin during muscle activation and relaxation.

Doran M, Rynkiewicz M, Pavadai E, Bodt S, Rasicci D, Moore J J Gen Physiol. 2022; 155(2).

PMID: 36459134 PMC: 9723511. DOI: 10.1085/jgp.202213274.

References
1.
Pospich S, Sweeney H, Houdusse A, Raunser S . High-resolution structures of the actomyosin-V complex in three nucleotide states provide insights into the force generation mechanism. Elife. 2021; 10. PMC: 8735999. DOI: 10.7554/eLife.73724. View

2.
Viswanathan M, Tham R, Kronert W, Sarsoza F, Trujillo A, Cammarato A . Myosin storage myopathy mutations yield defective myosin filament assembly in vitro and disrupted myofibrillar structure and function in vivo. Hum Mol Genet. 2017; 26(24):4799-4813. PMC: 5886249. DOI: 10.1093/hmg/ddx359. View

3.
Bhide S, Trujillo A, OConnor M, Young G, Cryderman D, Chandran S . Increasing autophagy and blocking Nrf2 suppress laminopathy-induced age-dependent cardiac dysfunction and shortened lifespan. Aging Cell. 2018; 17(3):e12747. PMC: 5946079. DOI: 10.1111/acel.12747. View

4.
Rao D, Kronert W, Guo Y, Hsu K, Sarsoza F, Bernstein S . Reductions in ATPase activity, actin sliding velocity, and myofibril stability yield muscle dysfunction in Drosophila models of myosin-based Freeman-Sheldon syndrome. Mol Biol Cell. 2018; 30(1):30-41. PMC: 6337914. DOI: 10.1091/mbc.E18-08-0526. View

5.
Rayment I, Rypniewski W, Smith R, Tomchick D, Benning M, Winkelmann D . Three-dimensional structure of myosin subfragment-1: a molecular motor. Science. 1993; 261(5117):50-8. DOI: 10.1126/science.8316857. View